Proteome Sciences plc

Research Proteome Sciences plc (PI2) on Bullrun: market cap EUR 5.14M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPI2
• ExchangeF
• CountryUnited Kingdom
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyEUR
• Market capEUR 5.14M
• Financial periodFY2025
• RevenueEUR 3.76M
• Revenue growth-23.1%
• Net income-EUR 3.06M
• Free cash flow-EUR 143.00K
• Gross margin-2.2%

Valuation Snapshot

latest market cap is EUR 5.14M.

About Proteome Sciences plc

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor;

Frequently asked questions

What is Proteome Sciences plc's market cap?

Proteome Sciences plc's market capitalization is EUR 5.14M.

What does Proteome Sciences plc do?

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.